5min chapter

Business Daily cover image

Denmark and the Novo Nordisk effect

Business Daily

CHAPTER

The Rise of GLP-1 Drugs in Anti-Obesity Market

Exploring Novo Nordisk's success in producing cutting-edge GLP-1 drugs for obesity treatment, touching upon the challenges faced by the company and the industry's response to global demand for diabetes and obesity solutions.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode